Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „weak“
Suchtreffer
Begriffe & Kennungen
Abasaglar (previously Abasria) · 4.5 · Beta-blockers, clonidine, lithium salts or alcohol may either potentiate or weaken the blood-glucose lowering
Eintrag öffnenAbasaglar (previously Abasria) · 4.5 · Beta-blockers, clonidine, lithium salts or alcohol may either potentiate or weaken the blood-glucose lowering
Eintrag öffnenAbdominal wall muscle weakness
Eintrag öffnenAdenuric · 4.5 · Desipramine/CYP2D6 substrates Febuxostat was shown to be a weak inhibitor of CYP2D6 in vitro. In a study in he
Eintrag öffnenAdenuric · 4.5 · Desipramine/CYP2D6 substrates Febuxostat was shown to be a weak inhibitor of CYP2D6 in vitro. In a study in he
Eintrag öffnenAdenuric · 4.5 · Rosiglitazone/CYP2C8 substrates Febuxostat was shown to be a weak inhibitor of CYP2C8 in vitro. In a study in
Eintrag öffnenAdenuric · 4.5 · Rosiglitazone/CYP2C8 substrates Febuxostat was shown to be a weak inhibitor of CYP2C8 in vitro. In a study in
Eintrag öffnenAgilus · 4.8 · 5 Musculoskeletal and Not known Muscle weakness, Muscle fatigue connective tissue disorders Renal and urinary
Eintrag öffnenAlecensa · 4.5 · CYP substrates In vitro, alectinib and M4 show weak time-dependent inhibition of CYP3A4, and alectinib exhibit
Eintrag öffnenAmbirix · 4.8 · Musculoskeletal and connective tissue disorders Arthritis, muscular weakness
Eintrag öffnenAmglidia · 4.5 · ACE inhibitors Potentiation of the Hypoglycaemia blood-glucose lowering effect Acetazolamide Weakening of the
Eintrag öffnenAnkle weakness
Eintrag öffnenAnoro Ellipta (previously Anoro) · 4.5 · Beta2-adrenergic blockers may weaken or antagonise the effect of beta2-adrenergic agonists, such as vilanterol
Eintrag öffnenAripiprazole Zentiva · 4.5 · When weak inhibitors of CYP3A4 (e.g. diltiazem) or CYP2D6 (e.g. escitalopram) are used concomitantly with arip
Eintrag öffnenAsthenie
Eintrag öffnenAtectura Breezhaler · 4.5 · Beta-adrenergic blockers may weaken or antagonise the effect of beta 2-adrenergic agonists. Therefore, this me
Eintrag öffnenAteminsuffizienz aufgrund von Muskelschwäche
Eintrag öffnenAugtyro · 4.8 · Muscular weakness AUGTYRO can cause muscle weakness with or without creatine phosphokinase (CPK) elevation. Am
Eintrag öffnenAvonex · 4.8 · not known systemic lupus erythematosus, muscle weakness, arthritis
Eintrag öffnenAvonex · 4.8 · not known systemic lupus erythematosus, muscle weakness, arthritis
Eintrag öffnen